Spinoffs, sales and tuck-ins top medtech deal priorities: Moody’s

After J&J’s $13.1 billion purchase of Shockwave Medical, Moody’s analysts see the potential for other larger pick-ups “if interest rates substantially decrease.”

By Nick Paul Taylor • April 19, 2024

Bruker to acquire Nanostring for $393M

Bruker made an offer roughly two months after Nanostring filed for bankruptcy protection and said it may restructure.

By Susan Kelly • April 18, 2024

Explore the Trendline➔

MedTech Dive Outlook 2022

The pandemic continues to disrupt the medical device industry early in 2022, as COVID-19 testing demand remains strong and nonemergent procedures are postponed. In this series, we look at the risks, challenges and opportunities ahead.

By MedTech Dive staff

Steris to sell dental segment for $787.5M

Divesting the business will allow Steris to repay debt and focus on its core markets of healthcare, pharma and medtech.

By Elise Reuter • April 11, 2024

J&J to acquire Shockwave Medical for $13.1B

The deal comes just over a week after The Wall Street Journal reported that the companies were discussing a merger.

By Ricky Zipp • Updated April 5, 2024

FTC asks Boston Scientific for more info on $3.7B Axonics deal

The company has pushed back its expected closing date for the acquisition due to the second request from the Federal Trade Commission.

By Susan Kelly • April 4, 2024

3M spins out Solventum

The new company will need to work through debt from the spinoff and sole-source arrangements with 3M.

By Elise Reuter • April 1, 2024

Labcorp inks $237.5M buyout of Opko’s reproductive, women’s health testing assets

The acquired assets generate about $100 million in annual revenue, according to the deal announcement.

By Nick Paul Taylor • March 29, 2024

Boston Scientific’s $3.7B Axonics buy tops list of medtech M&A in 2024

Medtech dealmaking has not yet taken off this year, but there have been a number of smaller tuck-in acquisitions and private equity agreements.

By Ricky Zipp • March 28, 2024

J&J in talks to buy Shockwave Medical: WSJ

The healthcare giant could follow up its $16.6 billion acquisition of Abiomed with another deal for a heart device company, the WSJ reported Tuesday.

By Ricky Zipp • March 27, 2024

Johnson Matthey to sell medical device components unit for $700M

The segment makes components for medical devices, such as nitinol and metallic coatings.

By Elise Reuter • March 20, 2024

Titan Medical to merge with imaging firm Conavi, ending strategic review

The combined company will focus on selling Conavi’s cardiovascular imaging system used in minimally invasive procedures.

By Elise Reuter • March 19, 2024

Haemonetics to buy Attune Medical for $160M

Attune’s device to help cool the esophagus during radiofrequency ablation procedures is a key piece of the acquisition.

By Susan Kelly • March 5, 2024

Baxter considers selling kidney care unit to private equity

The company expects to divest its largest segment, whether through a spinoff or a sale, in the second half of the year.

By Elise Reuter • March 4, 2024

Agiliti to go private in $2.5B PE deal

After the transaction’s expected close in the first half of this year, Agiliti will no longer trade on the New York Stock Exchange.

By Susan Kelly • Feb. 26, 2024

Ex-Mazor exec convicted of insider trading conspiracy linked to $1.6B Medtronic deal

A federal jury found Doron Tavlin guilty on one count of conspiracy to commit insider trading and 10 counts related to securities fraud.

By Nick Paul Taylor • Feb. 22, 2024

The top medtech trends in 2024

Experts said M&A, orthopedic procedure backlogs and emerging cardiac markets were among the top trends to watch in the medical device industry this year.

By MedTech Dive Staff • Jan. 31, 2024

Cook Medical sells ear, nose and throat devices to C2Dx

The transaction completes Cook’s divestiture of its otolaryngology, head and neck surgery product lines.

By Nick Paul Taylor • Jan. 26, 2024

Invitae sells reproductive health assets amid liquidity concerns

DNA testing firm Natera could pay up to $52.5 million total, and plans to move Invitae’s customers to its own tests.

By Elise Reuter • Jan. 22, 2024

Integer acquires Pulse Technologies for $140M

Pulse specializes in the micro machining of components for medical devices used in markets such as structural heart.

By Nick Paul Taylor • Jan. 16, 2024

5 medtech trends to watch in 2024

From the M&A outlook and tough year-over-year comparisons to emerging markets like pulsed field ablation, here are the top medical technology trends to watch this year.

By Ricky Zipp • Jan. 9, 2024

Boston Scientific to buy Axonics for $3.7B to gain incontinence treatment

The acquisition provides a high-growth addition to Boston Scientific’s urology business, analysts said.

By Susan Kelly • Jan. 8, 2024

‘Healthy pullback’: GSR Ventures’ Sunny Kumar on normalizing digital health funding, accelerating M&A in 2024

Sunny Kumar discusses digital healthcare investment, the landscape for M&A and when the public markets could open back up. 

By Emily Olsen • Jan. 8, 2024

Roche to buy LumiraDx’s point-of-care technology for $295M

LumiraDx faces financial pressures amid declining test sales and a potential delisting from the Nasdaq.

By Elise Reuter • Jan. 2, 2024

Roundup: Illumina’s long goodbye to cancer test maker Grail

From the start, the DNA sequencing leader faced pressure to unwind its $8 billion acquisition of the cancer screening developer. As 2023 drew to a close, it has finally agreed.

By Susan Kelly • Dec. 21, 2023

Stryker buys joint replacement business Serf Sas

The purchase is expected to complement Stryker’s business in Europe and its joint replacement portfolio.

By Elise Reuter • Dec. 20, 2023